RHOA and hepatocellular carcinoma: Gou et al found that high expression of RhoA protein was recognized in HCC compared with the paired nontumor tissues and was associated with poorer disease-free survival (DFS) in HCC patients, suggesting RhoA was a useful marker for predicting early recurrence in early-stage HCC [36].